Symposium in Utrecht on 9 June 2022
After a few COVID related postponements, admedicum was proud to host Patient Engagement in 2030 with the support of HollandBIO and INSMED Pharmaceuticals on 9 June 2022 in Utrecht at the historic Muntgebouw in Utrecht with over 70 attendees. Speakers from patient organisations, healthcare, regulatory and industry shared forward thinking perspectives towards solutions, improvements, and opportunities for patient engagement in 2030.
All participants had ample opportunities to exchange their expertise on patient engagement during the Q&A sessions, the parliamentary debate (moderated by Roger Legtenberg ⚛ (admedicum)), and the networking sessions. Here you can find some impressions on the event:
The consensus from the event is that patient engagement will continue to evolve towards patient AND public involvement in research with an increased focus on person centered, value-based healthcare. There is now ample evidence that patient engagement de risks medicines development and leads to better outcomes and societal impact. Thanks to EUPATI, PFMD, and other European initiatives the pool of patient experts is already large and still expanding.
“By 2030…Patients are at the center of drug development, supported by professionalization of the patient community, an ecosystem of expert organizations, and a social contract that requires bio pharma companies help build disease knowledge together with the entire community.”Ana Mingorance (during her speech)
Here you can also find the insights of several participants during this inspiring day and their views on how patient engagement will evolve towards 2030: